牛牛AI助理已提取核心訊息
AdvisorShares Trust, an investment company registered under Section 8 of the Investment Company Act of 1940, has filed a Schedule 13G with the United States Securities and Exchange Commission on February 14, 2024, indicating a significant ownership stake in Clearmind Medicine Inc. The filing, which is required due to the event that occurred on December 31, 2023, shows that AdvisorShares Trust holds 92,693 common shares of Clearmind Medicine, representing 5.48% of the company's class of securities. The shares are held with sole voting and dispositive power, suggesting that AdvisorShares Trust has both the right to vote and the right to dispose of the shares. The address of Clearmind Medicine's principal executive offices is listed as 101 – 1220 W 6 Ave, Vancouver BC, Canada. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Clearmind Medicine.
AdvisorShares Trust, an investment company registered under Section 8 of the Investment Company Act of 1940, has filed a Schedule 13G with the United States Securities and Exchange Commission on February 14, 2024, indicating a significant ownership stake in Clearmind Medicine Inc. The filing, which is required due to the event that occurred on December 31, 2023, shows that AdvisorShares Trust holds 92,693 common shares of Clearmind Medicine, representing 5.48% of the company's class of securities. The shares are held with sole voting and dispositive power, suggesting that AdvisorShares Trust has both the right to vote and the right to dispose of the shares. The address of Clearmind Medicine's principal executive offices is listed as 101 – 1220 W 6 Ave, Vancouver BC, Canada. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Clearmind Medicine.
根據1940年《投資公司法》第8條註冊的投資公司AdvisorShares Trust已於2024年2月14日向美國證券交易委員會提交了附表13G，表示擁有Clearmind Medicine Inc.的重要所有權。該文件是根據2023年12月31日發生的事件而必須提交的，顯示AdvisorShares Trust持有Clearmind Medicine 92,693股普通股，佔該公司5.48％ 證券類別。這些股票以唯一的投票權和處置權持有，這表明AdvisorShares Trust既有投票權，也有處置股份的權利。Clearmind Medicine的主要行政辦公室地址列爲加拿大不列顛哥倫比亞省溫哥華市西6大道101—1220號。該文件稱，這些股份是在正常業務過程中收購的，不是爲了改變或影響Clearmind Medicine的控制權。
根據1940年《投資公司法》第8條註冊的投資公司AdvisorShares Trust已於2024年2月14日向美國證券交易委員會提交了附表13G，表示擁有Clearmind Medicine Inc.的重要所有權。該文件是根據2023年12月31日發生的事件而必須提交的，顯示AdvisorShares Trust持有Clearmind Medicine 92,693股普通股，佔該公司5.48％ 證券類別。這些股票以唯一的投票權和處置權持有，這表明AdvisorShares Trust既有投票權，也有處置股份的權利。Clearmind Medicine的主要行政辦公室地址列爲加拿大不列顛哥倫比亞省溫哥華市西6大道101—1220號。該文件稱，這些股份是在正常業務過程中收購的，不是爲了改變或影響Clearmind Medicine的控制權。
有用
沒用